Waturu Holding A/S
Company announcement nr. 57
Fredericia, February 2nd 2021
The subsidiary Aquaturu A/S has received the first export order
A large American listed company within salmon farming has placed an order with the subsidiary Aquaturu A/S to supply technology that can reduce bacteria and algae in their aquaculture production.
The order includes delivery of one unit, at a standard price of DKK 238,000. The customer has confirmed that an expected positive performance can trigger a sale of an additional 9 units within 12 months.
Chairman Thomas Marschall states - "Aquaturu will contribute to a more sustainable production of fish. The new export order proves that the market for land-based freshwater farming is a business area that the company can expect a lot from over the coming years ".
About Waturu Holding A/S
Waturu Holding A/S is a Greentech company, which develops innovative water technology for heating or treating water, with the focus on ensuring bacteria-free water and reducing water and energy consumption for heating hot water in properties and thus ensuring CO2 savings. Waturu Holding A/S is a major shareholder in the medical company Watgen Medical A/S and in the technology company Aquaturu A/S.
Further information:
CEO Toke Reedtz, cell.: +45 5188 1262, e-mail: toke@waturu.com
Waturu Holding A/S
Sjællandsgade 32
7100 Vejle
Certified Adviser
Please view company announcement no. 55
Nasdaq First North Growth Market
Important links:
Websites:
www.waturu.com
Financial reports:
www.waturu.com/documents
Further press related news:
www.linkedin.com/company/waturu/
www.facebook.com/WaturuDenmark/
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Atico Mining Corporation17.9.2025 22:30:00 CEST | Press release
Atico Signs the Investment Protection Agreement with Government of Ecuador for its La Plata Project
Frontline plc.17.9.2025 22:06:51 CEST | Press release
FRO – Filing of Half Yearly Report
VCI Global Limited17.9.2025 21:00:00 CEST | Press release
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom